"How is the progress of Kechuang's future brain-computer connection VR?" Li Miaomiao asked.
A subordinate reported: "The first generation of brain-computer connection VR has been finalized, and the prototype has been used by Goose Factory and Ahri for corresponding software design."
"As for games that connect brain-computer VR devices, Goose Factory's previous designs have all been overturned internally."
Since the launch of Kechuang Biotechnology's brain-computer connection technology, it was previously only used on mobile phones. Later, the brain-computer connection prosthetic limbs were of greater demonstration significance than actual significance.
There have been internal discussions that brain-computer connection should be combined with VR, including when Lei Jun came to communicate with Cheng Gang several times and expressed that he hoped that Kechuang Biotech would optimize the brain-computer connection for VR, and then rice and Kechuang Biotech would cooperate. An epoch-making brain-computer connected VR device.
Things have been going wrong for Cheng Gang since June, and IDG assigned him to two biopharmaceutical companies specializing in mrna vaccines.
An angel investment company founded by Cheng Gang that focuses on the field of biomedicine, after a preliminary review of the two projects introduced by idg, they unanimously felt that they were high-quality projects.
Whether it is Aibo Biotechnology or Si Microbiology, they are two leading companies in the domestic mRNA field. Both their technical background and certain backgrounds are quite amazing.
After careful understanding, Cheng Gang agreed to invest. He invested 20 million RMB in each of the two companies.
Cheng Gang originally did not expect Si Microbiology and Abbot Biotech to defeat foreign pharmaceutical giants. They only needed to capture the domestic market.
What they are fighting for is the high valuation of listing on the Science and Technology Innovation Board. In the past two years, domestic companies in the biomedical field have been valued at hundreds of times pe.
As the general manager of a leading company on the Science and Technology Innovation Board, Cheng Gang can also play a certain role in assisting other companies in passing meetings on the Science and Technology Innovation Board.
It's just that God's calculations are not as good as those of humans. Americen's Pfizer took the lead in developing a specific drug with the help of Simmons.
Simmons has a magic brain, and with his help Pfizer's progress has improved dozens of times.
As soon as the specific medicine was released, the previous investment of domestic mrna companies was completely reduced to silent costs, and their valuation dropped by at least half.
Because your previous technical routes were all aimed at covid mutant strains, and now that there are specific drugs, your technical accumulation and data are of no value.
Si microorganisms and cyber organisms need to be fundamentally revalued. What they are worth is only their technical framework and technical personnel.
The market valuation has more than been cut in half, at least one third of what it was before.
Some people will say that if Pfizer's specific medicine cannot be approved, it will not be able to enter China, so the mRNA vaccine development route is still valuable.
But there is a very critical issue. Pfizer has proven that its technical route is correct. Even if China does not let Pfizer in, it will definitely develop its own special medicine along Pfizer's research and development route.
Instead of taking an untraveled mrna vaccine route.
I originally thought that if I bet on both ends, I would get at least one end. The result is that all efforts are in vain.
Cheng Gang's paper investment losses amounted to more than 20 million yuan. If there is no fundamental change in the logic of the industry, there will be no hope of getting back the investment.
Cheng Gang was in a daze for a while. As an industry veteran, he was shocked. I originally thought that by hedging my bets, I would be able to win more than ten times or even dozens of times as much as IPO.
As a result, my angel investment company got off to a bad start and only had enough liquidity to invest in one project.
However, because part of his energy was focused on his investment company, he made mistakes at work.
Zheng Li took this as an excuse to assign some of his responsibilities to Li Miaomiao.
Lei Jun chatted with Cheng Gang about brain-computer connection to VR. Cheng Gang naturally strongly supported it. He was also very optimistic about this direction and hoped that this project would allow him to regain Zheng Li's trust.
"The current operating methods of mainstream VR equipment are still too cumbersome and very unintelligent." Lei Jun said, "Brain-computer connection can completely solve this problem."
2021 is hailed by the industry as the first year of the Metaverse. As a new Internet giant, ByteDance has also invested in the Metaverse project.
Different from Facebook's fanfare, name change, and CEO Xiao Zha's various propaganda, Byte is a big mover and has almost no publicity.
It's all about action, not talk.
Byte acquired a company specializing in VR equipment in 2021. This company’s hot product in 2021, pico neo3, ranks second in global sales.
But even the latest VR device, pico neo3, was launched in May 21, and its operation method is still through buttons.
Regarding the button operations on the handle and the VR helmet, the handle can also play a certain auxiliary control role, but it still seems very bulky.
When smartphones evolved from the earliest buttons, to virtual buttons, and now to the brain-computer connection. Compared with smartphones, the control methods of VR devices have progressed too slowly.
Cheng Gang agreed: "We have always considered brain-computer connection VR internally, but VR equipment is a completely new field for Kechuang Biotechnology."
"We are more of a technology licensing company. If we want to make hardware, whether it is supply chain technology integration or mass production and sales, it will be a very big challenge for Kechuang Biotechnology."
The supply chain production of biomedicine is completely different from the supply chain production of digital products. You can say that they are essentially the same, but there are too many differences in the specific operational level.
In particular, VR equipment is a relatively heavy digital product, and a VR equipment involves many components. Digital products such as headphones, mice, and keyboards are relatively lightweight and have a very short production chain.
When Lei Jun heard this, he was secretly happy, "Well, if you don't understand Science and Technology Biotechnology, there will be no problem with rice."
"We can definitely cooperate. Kechuang Biotech has the technology in brain-computer connection, and Daimi has rich experience in the digital product supply chain. The two of us can achieve very good complementarity."
"At the same time, Rice is a long-term partner of Kechuang Biotech and one of the shareholders of Kechuang Biotech. We have a solid foundation of mutual trust."
"You and I have been colleagues for many years, and you, Director Zheng, are also old acquaintances and partners. We can definitely cooperate well in the field of brain-computer connection VR."
Cheng Gang also thought this way: "We will form an internal report first and then report it to Director Zheng. The specific resolution needs to be passed by the board of directors."
Lei Jun: "We can achieve cooperation by establishing a joint venture. Kechuang Biotechnology will invest in technology patents and funds, and Rice will also invest in technology patents and funds."
It is a very common method of cooperation between listed companies to jointly establish new subsidiaries.
In the past two years, new energy has been booming, and many upstream and downstream companies in the new energy industry chain have cooperated by establishing companies through cooperation.
For example, recently Yuntianhua, Enjie, Yiwei Lithium Energy and Huayou Cobalt jointly invested 51.7 billion yuan to build a new energy industry chain. They cooperated by establishing two joint ventures.
After the internal research report of Kechuang Biotech was reported, Zheng Li asked while chatting with Li Miaomiao: "What do you think of the cooperation methods reported by the company recently? We are cooperating with Rice to build a brain-computer connection VR."
Li Miaomiao looked at Zheng Li on the screen and felt a little annoyed, because Zheng Li would always only talk about work when looking for topics, and she didn't want to just talk about work:
“Is our brain-computer connection technology mature for application in VR?”
Zheng Li thought for a moment: "It's absolutely no problem. There is no essential difference between the brain-computer connection to control mobile phones and VR devices."
"And VR is easier to control. We can achieve more precise control and have richer functions."
“Because VR and human eyes are related in a closed space, more precise control can be achieved through eye-capturing technology.”
"At the same time, VR equipment can set up more abundant nerve points and capture more brain nerve signals, which can achieve better results."
"It's just that the technology needs to be modified to a certain extent, but the transformation process won't be very complicated."
Li Miaomiao is very direct: "If it were not for the long-term cooperative relationship between Lei Jun and us, there would be no need to consider rice in our cooperation."
“The only company that provides brain-computer connection technology is Kechuang Biotechnology, and there are many companies that can provide VR-related technology industry chain integration.”
"When we propose cooperation, whether it is OV, Samsung, or even Apple, they will agree."
"If we really want to make the best products right away, then cooperating with Apple is the best way. The premium that Apple's products can enjoy is unmatched by other manufacturers."
The product premium referred to here means that no matter how high the price of Apple's products is, consumers will buy it. For example, a polishing cloth launched by Apple can be sold for 145 RMB, and demand exceeds supply.
If Apple can sell it at a high price, then it can use the best parts for its products. Consumers pay the bill anyway, and they don’t have to skimp on suppliers like other mobile phone manufacturers.
Therefore, Fruit Chain is what these mobile phone suppliers want to join most. The profit of supplying the same parts to Apple is much higher than that of supplying rice.
"If we cooperate with Apple, we will have a real opportunity to create an epoch-making VR device and start the VR craze."
"The user base cultivated by previous VR equipment will all become our nourishment."
Li Miaomiao paused: "But this is the way to maximize profits. From my personal heart, I prefer to cooperate with Chinese manufacturers."
"Instead of sharing all the profits with Apple, I hope to cultivate upstream and downstream enterprises in China's VR industry chain."
"For example, if we cooperate with Apple, Chinese companies in this industrial chain can only get a small part of it, and a lot of it will be distributed to other countries."
"And when we cooperate with rice, the profits, jobs, and capital flows brought by the industrial chain will completely stay in China."
"And we can take a dominant position by cooperating with rice, but we may not be able to take a dominant position by cooperating with Apple."
"So whether it's cooperating with rice or Apple, there are pros and cons."
Zheng Li interrupted: "Who do you want to cooperate with?"
Li Miaomiao: "Dami, but if we want to talk, our choices should not be limited to the rice family."
Zheng Li: "I also think we can cooperate with Rice. There is another risk in cooperating with Apple, which is the leakage of technology patents."
"They cannot steal technology patents during the cooperation process, but our R&D routes and logic are bound to be leaked to a certain extent."
Li Miaomiao added: "So we can leak the news. This is called Jiang Taigong fishing, and whoever is willing will take the bait."
"Although I feel sorry for you, senior brother, after all, shopping malls are like battlefields."
Kechuang Biotechnology plans to enter the field of VR. After the news about the combination of VR and brain-computer connection spread in the industry, I did not expect that the first company to come to our door was neither rice nor ov.
The first company that came to our door was Goose Factory.
Ren Yu, the president of Echang Interactive Entertainment Group, personally led a team to the door.
When the mobile Internet was on the rise, Goose Factory was the first among the three giants to get a ticket to the mobile Internet.
And Qiandu still hasn't got the mobile Internet ticket today, and his life is getting worse every day.
What best reflects the company's development is its market value. Qiandu's market value at this time was only HKD 450 billion.
ByteDance's valuation is 2.2 trillion, Meituan's market value is also listed on the Hong Kong stock market with a market value of 1.1 trillion hkd, and JD.com's Hong Kong stock market value is 900 billion hkd.
It’s just that Ant Group, which was hatched within Ali, was valued at 2 trillion RMB before something happened. Now that it has been cut in half and cut by 30%, its valuation is also 700 billion RMB.
Qiandu is lagging behind among second-tier Internet giants, not to mention lagging behind in BAT.
Seeing the bleak end of Qiandu, Goose Factory hopes to seize every opportunity, so their investment is the best among Internet giants.
Goose Factory is keenly aware that the brain-computer connection VR that Kechuang Biotechnology is developing is likely to be the direction of the next Internet revolution, or at least a new high-quality track.
The track means that new profits, new enterprises, and new industrial models will emerge.
Therefore, the Goose Factory attaches great importance to this cooperation, and Ren Yu took the initiative in the first intention negotiation.
Ren Yu has worked in Goose Factory for more than 20 years. He has served as the chief operating officer of Goose Factory since 2012. He is now the chief operating officer and the president of the Platform and Content Business Group and the Interactive Entertainment Business Group.
"Mr. Cheng, we met again. I was very optimistic about Kechuang Biotech's B-round investment before. At that time, I repeatedly emphasized to Li Zhaohui that I would participate in Kechuang Biotech's B-round investment at all costs. "
"Unfortunately, Kechuang Biotechnology is more popular than we internally estimated, so we can only bear to watch other institutions participate in the B-round investment."
"But fortunately, it's never too late to cooperate. Recently I heard that Kechuang Biotech is going to build a VR device for brain-computer connection. I wonder if Goose Factory is honored to cooperate with Kechuang Biotech to jointly open up a new track and achieve something great. Great cause!”
People in the Internet industry like to talk about the track. Invest in all the leading companies in the track at the same time. No matter who wins in the end, the investors will make money.
The Gu breeding ground is euphemistically called the racing track.
Cheng Gang hit him with a set of Tai Chi: "Brain-computer connection VR is just our internal research. As for whether it is really going to be implemented, we still need internal research to decide."
"The goose factory has almost no overlap with our previous industries, so there were no good opportunities for cooperation before."
"If Kechuang Biotech really wants to connect brain-computer VR in the future, it will definitely rely on the rich software ecosystem of Goose Factory."
